BIOREM Inc.
BIRMF
$1.66
-$0.14-7.78%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 552.80% | -3.53% | -85.08% | 355.91% | 643.62% |
| Total Depreciation and Amortization | 147.53% | 0.18% | -62.27% | 297.53% | -11.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 370.17% | 1.39% | -71.06% | 171.62% | 431.79% |
| Change in Net Operating Assets | 94.97% | -168.40% | 216.93% | -270.30% | 159.70% |
| Cash from Operations | 263.61% | -144.75% | 10,889.01% | -98.53% | 182.60% |
| Capital Expenditure | 100.00% | 99.00% | -403.61% | 149.39% | 33.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 99.00% | -403.61% | 149.39% | 33.78% |
| Total Debt Issued | -- | -- | -- | -- | -297.30% |
| Total Debt Repaid | -18.65% | 25.34% | -133.30% | 89.87% | -482.22% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -18.99% | 26.41% | -135.56% | 92.76% | -6,881.51% |
| Foreign Exchange rate Adjustments | 553.17% | 211.63% | 115.30% | 23.80% | -157.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 269.24% | -154.52% | 4,090.91% | -111.28% | 125.68% |
